2 results
Approved WMORecruitment stopped
To determine the optimal therapy for patients with pT1-2 pN0 oral and oropharyngeal cancer
Approved WMORecruitment stopped
To enumerate and characterize CTC in patients with solid malignancies before and, if applicable, after initiation of systemic treatment in order to improve the insight in the pathogenesis of metastases, and in mechanisms conferring resistance…